Phase 1 Clinical Study will Evaluate ADI-001 Safety and Efficacy in Patients with B-cell non-Hodgkin’s lymphoma MENLO PARK, Calif. and BO...
Helping Create
Life Science Success Stories
SBI JI Innovation Funds invest in exceptional VC-backed life science companies with their feet on the ground and their heads in the stars.
Investing in
The Most Exciting Technologies
Cures for serious, early-onset rare diseases by combining the best of gene therapy and gene editing
With a track record of over 1,200 investments, we are committed to Israel through our local office, SBI JI Innovation. We have already invested in top-tier biotech startups with disruptive technologies.
We strive to create an ecosystem that serves as a bridge between Israel and Asia.
Recent News
Orasis Advances Presbyopia Candidate to Phase 3 Clinical Trials HERZLIYA, Israel, September 10, 2020 – Orasis Pharmaceuticals, an emergin...
Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic Adeno...